NASDAQ:GLMD

Galmed Pharmaceuticals News Headlines

$3.07
-0.11 (-3.46 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$3.03
Now: $3.07
$3.19
50-Day Range
$3.19
MA: $3.56
$4.11
52-Week Range
$2.96
Now: $3.07
$6.29
Volume279,103 shs
Average Volume380,599 shs
Market Capitalization$77.01 million
P/E RatioN/A
Dividend YieldN/A
Beta2.3

Headlines

Galmed Pharmaceuticals (NASDAQ GLMD) News Headlines Today

SourceHeadline
Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) to Post -$0.44 Earnings Per ShareZacks: Analysts Anticipate Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) to Post -$0.44 Earnings Per Share
americanbankingnews.com - April 7 at 10:14 PM
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below Two Hundred Day Moving Average of $3.67Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below Two Hundred Day Moving Average of $3.67
americanbankingnews.com - April 3 at 1:36 AM
Galmed Pharmaceuticals (NASDAQ:GLMD) PT Lowered to $25.00Galmed Pharmaceuticals (NASDAQ:GLMD) PT Lowered to $25.00
americanbankingnews.com - March 25 at 9:00 AM
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Given Average Recommendation of "Buy" by AnalystsGalmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Given Average Recommendation of "Buy" by Analysts
americanbankingnews.com - March 24 at 2:42 AM
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q4 2020 Results - Earnings Call TranscriptGalmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 3:24 AM
Galmed Dips 2% On Larger-Than-Expected Quarterly LossGalmed Dips 2% On Larger-Than-Expected Quarterly Loss
finance.yahoo.com - March 19 at 12:06 PM
Galmed Pharmaceuticals: Q4 Earnings SnapshotGalmed Pharmaceuticals: Q4 Earnings Snapshot
finance.yahoo.com - March 18 at 7:55 AM
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial ResultsGalmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results
finance.yahoo.com - March 18 at 7:55 AM
Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MERGalmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MER
finance.yahoo.com - March 16 at 12:35 PM
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18
finance.yahoo.com - March 11 at 12:59 PM
Galmed Pharmaceuticals Announces Proposed Offering of Ordinary SharesGalmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
finance.yahoo.com - February 16 at 9:59 AM
Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary SharesGalmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares
finance.yahoo.com - February 16 at 9:59 AM
These 2 Penny Stocks Could Rack up Triple-Digit Gains, Say AnalystsThese 2 Penny Stocks Could Rack up Triple-Digit Gains, Say Analysts
finance.yahoo.com - February 11 at 1:04 PM
Are Institutions Heavily Invested In Galmed Pharmaceuticals Ltd.s (NASDAQ:GLMD) Shares?Are Institutions Heavily Invested In Galmed Pharmaceuticals Ltd.'s (NASDAQ:GLMD) Shares?
finance.yahoo.com - February 4 at 9:34 AM
Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchols Novel Anti-Fibrotic Mechanism of ActionGalmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol's Novel Anti-Fibrotic Mechanism of Action
finance.yahoo.com - January 26 at 12:38 PM
Galmed Hosting KOL Symposium and Pipeline UpdateGalmed Hosting KOL Symposium and Pipeline Update
finance.yahoo.com - January 19 at 7:01 PM
Is Galmed Pharmaceuticals Ltd (GLMD) A Good Stock To Buy?Is Galmed Pharmaceuticals Ltd (GLMD) A Good Stock To Buy?
finance.yahoo.com - December 4 at 4:25 PM
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q3 2020 Results - Earnings Call TranscriptGalmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 7:06 PM
Galmed Pharmaceuticals Ltd. to Host Earnings CallGalmed Pharmaceuticals Ltd. to Host Earnings Call
finance.yahoo.com - November 12 at 9:05 AM
Galmed Pharmaceuticals Reports Third Quarter 2020 Financial ResultsGalmed Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 12 at 9:05 AM
Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for AramcholGalmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
finance.yahoo.com - November 9 at 8:28 AM
Galmed Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on Thursday November 12Galmed Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on Thursday November 12
finance.yahoo.com - November 5 at 12:16 PM
We're Hopeful That Galmed Pharmaceuticals (NASDAQ:GLMD) Will Use Its Cash WiselyWe're Hopeful That Galmed Pharmaceuticals (NASDAQ:GLMD) Will Use Its Cash Wisely
finance.yahoo.com - October 20 at 8:43 AM
Galmed collaborates with Gannex Pharma for development programs in NASHGalmed collaborates with Gannex Pharma for development programs in NASH
seekingalpha.com - September 9 at 8:35 AM
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
benzinga.com - September 9 at 6:40 AM
Intercepts (ICPT) Q2 Earnings and Revenues Beat EstimatesIntercept's (ICPT) Q2 Earnings and Revenues Beat Estimates
nasdaq.com - August 11 at 9:27 AM
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2020 Results - Earnings Call TranscriptGalmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 1:50 PM
Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER programGalmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
finance.yahoo.com - August 6 at 8:47 AM
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsGalmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 8:47 AM
Galmed Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on Thursday August 6Galmed Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on Thursday August 6
finance.yahoo.com - July 30 at 9:08 AM
How Is Galmed Pharmaceuticals (NASDAQ:GLMD) CEO Paid Relative To Peers?How Is Galmed Pharmaceuticals' (NASDAQ:GLMD) CEO Paid Relative To Peers?
finance.yahoo.com - July 22 at 3:07 PM
How Is Galmed Pharmaceuticals' (NASDAQ:GLMD) CEO Paid Relative To Peers?How Is Galmed Pharmaceuticals' (NASDAQ:GLMD) CEO Paid Relative To Peers?
finance.yahoo.com - July 22 at 3:07 PM
Stock Alert: Galmed Pharma Shares Up 24%Stock Alert: Galmed Pharma Shares Up 24%
markets.businessinsider.com - July 15 at 12:59 PM
Intercept Slumps as the FDA Issues CRL to NASH CandidateIntercept Slumps as the FDA Issues CRL to NASH Candidate
www.nasdaq.com - June 30 at 1:45 PM
How Galmed (GLMD) Stock Stands Out in a Strong IndustryHow Galmed (GLMD) Stock Stands Out in a Strong Industry
finance.yahoo.com - June 10 at 12:16 PM
Hedge Funds Nibbling On Eton Pharmaceuticals, Inc. (ETON)Hedge Funds Nibbling On Eton Pharmaceuticals, Inc. (ETON)
finance.yahoo.com - June 4 at 7:31 PM
Edited Transcript of GLMD earnings conference call or presentation 14-May-20 12:30pm GMTEdited Transcript of GLMD earnings conference call or presentation 14-May-20 12:30pm GMT
finance.yahoo.com - May 14 at 11:57 PM
Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call TranscriptGalmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 6:56 PM
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial ResultsGalmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 8:32 AM
Galmed Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on Thursday May 14Galmed Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on Thursday May 14
finance.yahoo.com - May 7 at 12:19 PM
Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial ResultsGalmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results
www.bloomberg.com - May 5 at 8:34 PM
Such Is Life: How Galmed Pharmaceuticals (NASDAQ:GLMD) Shareholders Saw Their Shares Drop 54%Such Is Life: How Galmed Pharmaceuticals (NASDAQ:GLMD) Shareholders Saw Their Shares Drop 54%
finance.yahoo.com - May 2 at 5:33 PM
Galmed Pharmaceuticals Ltd.Galmed Pharmaceuticals Ltd.
www.barrons.com - March 26 at 12:19 AM
Edited Transcript of GLMD earnings conference call or presentation 12-Mar-20 12:30pm GMTEdited Transcript of GLMD earnings conference call or presentation 12-Mar-20 12:30pm GMT
finance.yahoo.com - March 12 at 11:08 PM
Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q4 2019 Results - Earnings Call TranscriptGalmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 6:08 PM
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2019 Financial ResultsGalmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2019 Financial Results
finance.yahoo.com - March 12 at 8:07 AM
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2019 Financial Results and Provide Business Update on Thursday March 12Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2019 Financial Results and Provide Business Update on Thursday March 12
finance.yahoo.com - March 5 at 9:27 AM
BioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% HigherBioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% Higher
finance.yahoo.com - February 28 at 12:41 PM
ARMP Soars, SAVA Awaits Alzheimers Data, HEPA On The Move, All Eyes On AIMTARMP Soars, SAVA Awaits Alzheimer's Data, HEPA On The Move, All Eyes On AIMT
www.nasdaq.com - January 28 at 9:51 PM
Is Galmed Pharmaceuticals Ltd.s (NASDAQ:GLMD) CEO Overpaid Relative To Its Peers?Is Galmed Pharmaceuticals Ltd.'s (NASDAQ:GLMD) CEO Overpaid Relative To Its Peers?
finance.yahoo.com - January 3 at 5:11 PM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.